ImmuCell Co. (NASDAQ:ICCC – Get Free Report) crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $3.96 and traded as high as $4.63. ImmuCell shares last traded at $4.41, with a volume of 24,463 shares traded.
ImmuCell Price Performance
The firm has a market cap of $39.30 million, a P/E ratio of -8.82 and a beta of 0.60. The company has a quick ratio of 1.44, a current ratio of 3.11 and a debt-to-equity ratio of 0.36. The business has a fifty day moving average of $3.93 and a 200 day moving average of $3.96.
ImmuCell Company Profile
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E.
Read More
- Five stocks we like better than ImmuCell
- How to Most Effectively Use the MarketBeat Earnings Screener
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What is a buyback in stocks? A comprehensive guide for investors
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Investing in Construction Stocks
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for ImmuCell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuCell and related companies with MarketBeat.com's FREE daily email newsletter.
